Methotrexate reduces withdrawal rates of TNF inhibitors due to ineffectiveness in rheumatoid arthritis but only in patients who are seropositive.
Mandy GreenwoodMuhammad ShipaSu-Ann YeohEuthalia RoussouDev MukerjeeMichael R EhrensteinPublished in: Annals of the rheumatic diseases (2020)